# Glycemic Control on Coronary Inflammation Evaluated by FAI in ACS

> **NCT05590858** · — · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 309 (actual)

## Conditions studied

- Inflammation Vascular

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05590858
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2022-10-01
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590858, "Glycemic Control on Coronary Inflammation Evaluated by FAI in ACS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05590858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*